AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

OHRP seeks comments on draft guidance on adverse events.(Office for Human Research Protection)

Research Practitioner

| November 01, 2005 | COPYRIGHT 2003 Jobson Medical Information LLC. (Hide copyright information)Copyright

OHRP is soliciting public comment on a draft guidance for IRBs, investigators, research institutions, and HHS agencies that conduct or sponsor research on human subjects, and other interested parties. The document is titled Guidance on Reporting and Reviewing Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others. The draft guidance can be viewed by clicking on the "News" links at the OHRP web site.

For many years the IRB and research communities have requested that federal regulatory agencies provide harmonized guidelines and requirements for reporting adverse events in the context of research involving human subjects. Most recently, the …

Related articles from newspapers, magazines, journals, and more
FDA draft guidance on gene therapy adverse events.(Regulatory Update)
Newspaper article from: Research Practitioner September 1, 2005 700+ words
FDA issues draft guidance on adverse event reporting.(Regulatory Update)
Newspaper article from: Research Practitioner May 1, 2007 700+ words
International cooperation on harmonisation of technical requirements for...
News wire article from: Chemical Business Newsbase May 2, 2006 700+ words
FDA guidance on delayed adverse events in gene therapy trials.(Regulatory...
Newspaper article from: Research Practitioner January 1, 2007 700+ words
CIs should be first to report adverse events, not IRBs, SACHRP advises; FDA...
Newspaper article from: Bioresearch Monitoring Alert Sami, Tamra January 1, 2004 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily